1/25
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
What are the most important aspect of reparation, verification, and administration of compounded sterile preparations (CSPs)?
Compatibility and stability
What does the quality of final preparation depends on?
compatibility and stability parameters
What can incompatibility cause?
Harm or death of patients
What are some peripheral IV considerations?
Veins in extremities preferred for peripheral access
Obtaining and maintaining IV access in infants and young children challenging
Osmolarity through peripheral lines should be limited
Typically between 700-900 mOsm/L
As high as 900 to 1100 mOsm/L may be tolerated
Some recommend max of 600 mOsm/L
What are some central IV access considerations?
Central venous catheters (CVCs) necessary for prolonged IV therapy
Insertion of catheter into large veins
Fewer problems with extravasation and infiltration
Broviac, Hickman, Groshong catheters
Higher osmolarities of solutions tolerated
1500 to 2000 mOsm/L
Aspects of intraosseous (IO) access
Used very rarely in emergency situations when IV access cannot be obtained
Inserted into anteromedial surface of tibia
Highly vascularized long bone marrow
Intended for less than 6 hours
Tolerates osmolarities and drug concentrations as with CVC
What are the fundalmentals of stability?
Stability refers to the retention of properties and characteristics throughout the storage and use periods
Instability results when a change or degradation of the active ingredients occurs
Stability parameters established secondary to exposure testing by the manufacturer
What are the types of stability?
Chemical
Physical
Toxicological
Therapeutic
Microbiological
What factors influence stability?
Concentration of medication
Packaging
Exposure to Light
Temperature
Medication delivery devices (tubing, syringes, etc.)
What difference between BUD and expiration date?
expiration date
Assigned by the manufacturer
Determined using extensive analytical testing
Beyond-use Dates
Assigned by a pharmacist
Determined based on available scientific evidence or per manufacturer recommendations
How to determine DUB
Must consider Sterility and Stability data
USP Chapter <797> provides guidance on determining BUD regarding Sterility
Chemical Stability BUD often extrapolated based on:
Direct testing or literature
Manufacturer information
Theoretical predictions
The lesser of the 2 BUDs above is the BUD assigned
Aspect of 797 BUD
Category 1 (PEC in normal room air)
12 hours at room temperature
24 hours refrigerated
Category 2 (PEC located in ISO7 buffer room with ISO8 ante room)
4 days at room temperature
10 days in the refrigerator
45 days in the freezer
What are the fundamental of imcompatibility
Undesirable reaction that can occur between:
Two drug substances
A drug substance and an excipient
Drug substance or excipient with container
What are the types of imcompatibility
Physical
Chemical
What are some physical incompatibilities
Crystallization
Precipitation
Sorption and leaching
What are some chemical incompatibilities
Hydrolysis
Oxidation
Complexation
Displacement
Evolution of gas
What are some factors that influence incompatibilities?
Temperature
pH
Concentration
Light
Time
Mixing sequence
What are some therapeutic influences on incompatibilities?
Chemical or physical incompatibilities can result in influences in therapeutic efficacy of drugs
Loss of efficacy of one or more of active ingredients when administered together
Can administer separately or with adequate time between drugs
Aspects of Calcium Phosphate incompatibilities
Formed when calcium salts are added to electrolytes containing phosphate
Chemical reaction physically manifested as formation of precipitates or haze in preparation
Aspects of Parenteral Nutrition
Parenteral nutrition (PN) is a common source of incompatibilities resulting in calcium phosphate
Calcium and phosphorous are part of nutrition provided parenterally
Nutrition preparations for neonates at high risk of incompatibility
What are the risk involved in Parenteral Nutrition?
Suboptimal delivery of calcium and phosphorous
Occlusion of in-line filter
Microvascular embolism
Pulmonary embolism
What are ways of preventing Calcium Phosphate?
Utilize calcium gluconate over calcium chloride
Maintain low pH of final admixture
Increase amino acid concentration
Store at lower temperatures
Avoid higher temperatures during administration
Do not add calcium and phosphate salts in close sequence
Calculate solubility of calcium
Use volume of admixture at time calcium is added
Aspect of utilize resource in terms of preventing incompatibilities
important to utilize compatibility resources to predict incompatibilities and determine drug characteristics
Package inserts
Drug databases with compatibility features
Books and incompatibility charts
Handbook on Injectable Drugs
King Guide to Parenteral Admixtures
Primary literature
How to minimize risk of incompatibilities
Use preparation shortly after compounding
Minimize the number of drugs in a single preparation
Utilize references and resources to determine compatibility and stability
Closely review preparations with high or low pH
Closely review preparations containing calcium, phosphate, or magnesium
Aspects of visual inspects in terms of identifying incompatibilities
Preparation should be adequately agitated/mixed
Add components that will limit visual identification of incompatibilities last
Hold final preparation up to light to see through
Check against a contrasting background
What to look for when inspecting for incompatibilities?
Hazy/cloudy appearance
Precipitates
Color change
Formation of gas
Separation of contents
Temperature changes
Crystallization